Monitoring Strategy Baseline (before starting): Complete pain assessment with validated tools Neurological examination Basic metabolic panel, HbA1c (if diabetic), vitamin B12, TSH INR if on warfarin Cardiovascular risk assessment Ongoing: Pain assessment every 4-8 weeks initially, then every 12 weeks INR weekly 2 weeks then monthly if on warfarin Neurological examination every 6-12 months Annual laboratory monitoring for long-term use 4
These protocols are based on clinical observation, not randomized controlled trials
That discovery launched over four decades of continuous scientific investigation, and what researchers have found since then paints a compelling picture
Peptide research is about asking if we can reverse the damage that caused the crisis in the first place
3.4.2 Cancer-focused evidence In prostate cancer models (PC3, DU145), curcumin reduces the stability of the oncogenic m 6 A-modified circRNA (circ0030568) by suppressing METTL3 writer dependent methylation, which adds m 6 A marks, and down-regulating the YTHDF2 that normally binds and protects circ0030568 from degradation